scholarly journals Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway

2003 ◽  
Vol 278 (46) ◽  
pp. 45117-45127 ◽  
Author(s):  
Hyung-Kyu Lim ◽  
Young-Ae Choi ◽  
Wan Park ◽  
Taehoon Lee ◽  
Sung Ho Ryu ◽  
...  
1999 ◽  
Vol 274 (48) ◽  
pp. 34493-34498 ◽  
Author(s):  
Shuji Isotani ◽  
Kenta Hara ◽  
Chiharu Tokunaga ◽  
Hitomi Inoue ◽  
Joseph Avruch ◽  
...  

2006 ◽  
Vol 5 (11) ◽  
pp. 2815-2823 ◽  
Author(s):  
Patrick Yoon ◽  
Nick Giafis ◽  
Jessica Smith ◽  
Heather Mears ◽  
Efstratios Katsoulidis ◽  
...  

2012 ◽  
Vol 26 (4) ◽  
pp. 669-680 ◽  
Author(s):  
Astrid Musnier ◽  
Kelly León ◽  
Julia Morales ◽  
Eric Reiter ◽  
Thomas Boulo ◽  
...  

Abstract FSH is a key hormonal regulator of Sertoli cell secretory activity, required to optimize sperm production. To fulfil its biological function, FSH binds a G protein-coupled receptor, the FSH-R. The FSH-R-transduced signaling network ultimately leads to the transcription or down-regulation of numerous genes. In addition, recent evidence has suggested that FSH might also regulate protein translation. However, this point has never been demonstrated conclusively yet. Here we have addressed this issue in primary rat Sertoli cells endogenously expressing physiological levels of FSH-R. We observed that, within 90 min of stimulation, FSH not only enhanced overall protein synthesis in a mammalian target of rapamycin-dependent manner but also increased the recruitment of mRNA to polysomes. m7GTP pull-down experiments revealed the functional recruitment of mammalian target of rapamycin and p70 S6 kinase to the 5′cap, further supported by the enhanced phosphorylation of one of p70 S6 kinase targets, the eukaryotic initiation factor 4B. Importantly, the scaffolding eukaryotic initiation factor 4G was also recruited, whereas eukaryotic initiation factor 4E-binding protein, the eukaryotic initiation factor 4E generic inhibitor, appeared to play a minor role in translational regulations induced by FSH, in contrast to what is generally observed in response to anabolic factors. This particular regulation of the translational machinery by FSH stimulation might support mRNA-selective translation, as shown here by quantitative RT-PCR amplification of the c-fos and vascular endothelial growth factor mRNA but not of all FSH target mRNA, in polysomal fractions. These findings add a new level of complexity to FSH biological roles in its natural target cells, which has been underappreciated so far.


2003 ◽  
Vol 278 (18) ◽  
pp. 15461-15464 ◽  
Author(s):  
Hiroki Nojima ◽  
Chiharu Tokunaga ◽  
Satoshi Eguchi ◽  
Noriko Oshiro ◽  
Sujuti Hidayat ◽  
...  

2003 ◽  
Vol 278 (28) ◽  
pp. 26302
Author(s):  
Hiroki Nojima ◽  
Chiharu Tokunaga ◽  
Satoshi Eguchi ◽  
Noriko Oshiro ◽  
Sujuti Hidayat ◽  
...  

2009 ◽  
Vol 421 (1) ◽  
pp. 29-42 ◽  
Author(s):  
Juan M. García-Martínez ◽  
Jennifer Moran ◽  
Rosemary G. Clarke ◽  
Alex Gray ◽  
Sabina C. Cosulich ◽  
...  

mTOR (mammalian target of rapamycin) stimulates cell growth by phosphorylating and promoting activation of AGC (protein kinase A/protein kinase G/protein kinase C) family kinases such as Akt (protein kinase B), S6K (p70 ribosomal S6 kinase) and SGK (serum and glucocorticoid protein kinase). mTORC1 (mTOR complex-1) phosphorylates the hydrophobic motif of S6K, whereas mTORC2 phosphorylates the hydrophobic motif of Akt and SGK. In the present paper we describe the small molecule Ku-0063794, which inhibits both mTORC1 and mTORC2 with an IC50 of ∼10 nM, but does not suppress the activity of 76 other protein kinases or seven lipid kinases, including Class 1 PI3Ks (phosphoinositide 3-kinases) at 1000-fold higher concentrations. Ku-0063794 is cell permeant, suppresses activation and hydrophobic motif phosphorylation of Akt, S6K and SGK, but not RSK (ribosomal S6 kinase), an AGC kinase not regulated by mTOR. Ku-0063794 also inhibited phosphorylation of the T-loop Thr308 residue of Akt phosphorylated by PDK1 (3-phosphoinositide-dependent protein kinase-1). We interpret this as implying phosphorylation of Ser473 promotes phosphorylation of Thr308 and/or induces a conformational change that protects Thr308 from dephosphorylation. In contrast, Ku-0063794 does not affect Thr308 phosphorylation in fibroblasts lacking essential mTORC2 subunits, suggesting that signalling processes have adapted to enable Thr308 phosphorylation to occur in the absence of Ser473 phosphorylation. We found that Ku-0063794 induced a much greater dephosphorylation of the mTORC1 substrate 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1) than rapamycin, even in mTORC2-deficient cells, suggesting a form of mTOR distinct from mTORC1, or mTORC2 phosphorylates 4E-BP1. Ku-0063794 also suppressed cell growth and induced a G1-cell-cycle arrest. Our results indicate that Ku-0063794 will be useful in delineating the physiological roles of mTOR and may have utility in treatment of cancers in which this pathway is inappropriately activated.


Sign in / Sign up

Export Citation Format

Share Document